Foundry Cash Factor ETF
ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Hypothetical growth of $1 — long-short backtest
Gross of the placeholder expense ratio and trading costs · not investor results
Holdings
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1CRWD | CROWDSTRIKE HOLDINGS INC | Technology | $206.79B | 9.62% |
2APP | APPLOVIN CORP | Technology | $142.62B | 6.63% |
3BKNG | BOOKING HOLDINGS INC | Industrials | $140.78B | 6.55% |
4BNY | BANK OF NEW YORK MELLON CORP | Financial Services | $107.85B | 5.02% |
5HOOD | ROBINHOOD MARKETS INC | Financial Services | $90.01B | 4.19% |
6BE | BLOOM ENERGY CORP | Industrials | $61.14B | 2.84% |
7LITE | LUMENTUM HOLDINGS INC | Technology | $57.01B | 2.65% |
8STT | STATE STREET CORP | Financial Services | $50.51B | 2.35% |
9LYV | LIVE NATION ENTERTAINMENT INC | Communication Services | $42.45B | 1.97% |
10COIN | COINBASE GLOBAL INC | Financial Services | $41.40B | 1.93% |
11CBRS | CEREBRAS SYSTEMS INC | Technology | $39.16B | 1.82% |
12RKLB | ROCKET LAB CORP | Industrials | $39.14B | 1.82% |
13NTRA | NATERA INC | Healthcare | $38.87B | 1.81% |
14CRDO | CREDO TECHNOLOGY GROUP HOLDING LTD | Technology | $37.80B | 1.76% |
15ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | $35.71B | 1.66% |
16RDDT | REDDIT INC | Communication Services | $34.88B | 1.62% |
17ONC | BEONE MEDICINES LTD | Healthcare | $34.68B | 1.61% |
18CPNG | COUPANG INC | Consumer Cyclical | $29.83B | 1.39% |
19CPRT | COPART INC | Industrials | $25.56B | 1.19% |
20VRSN | VERISIGN INC | Technology | $25.27B | 1.18% |
21SYM | SYMBOTIC INC | Industrials | $24.86B | 1.16% |
22CPAY | CORPAY INC | Technology | $23.91B | 1.11% |
23INCY | INCYTE CORP | Healthcare | $23.42B | 1.09% |
24ASTS | AST SPACEMOBILE INC | Technology | $22.43B | 1.04% |
25ROKU | ROKU INC | Communication Services | $21.32B | 0.99% |
26GH | GUARDANT HEALTH INC | Healthcare | $20.67B | 0.96% |
27TOST | TOAST INC | Technology | $17.45B | 0.81% |
28BBIO | BRIDGEBIO PHARMA INC | Healthcare | $15.94B | 0.74% |
29CRCL | CIRCLE INTERNET GROUP INC | Financial Services | $15.03B | 0.70% |
30DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | $14.79B | 0.69% |
31LOGI | LOGITECH INTERNATIONAL SA | Technology | $14.76B | 0.69% |
32SITM | SITIME CORP | Technology | $14.65B | 0.68% |
33QNT | QUANTINUUM INC | Technology | $14.54B | 0.68% |
34MLI | MUELLER INDUSTRIES INC | Industrials | $13.08B | 0.61% |
35U | UNITY SOFTWARE INC | Technology | $12.66B | 0.59% |
36AXSM | AXSOME THERAPEUTICS INC | Healthcare | $11.84B | 0.55% |
37W | WAYFAIR INC | Consumer Cyclical | $11.79B | 0.55% |
38MOH | MOLINA HEALTHCARE INC | Healthcare | $11.74B | 0.55% |
39BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | $11.52B | 0.54% |
40VICR | VICOR CORP | Technology | $10.83B | 0.50% |
41KRYS | KRYSTAL BIOTECH INC | Healthcare | $10.46B | 0.49% |
42APGE | APOGEE THERAPEUTICS INC | Healthcare | $10.10B | 0.47% |
43GME | GAMESTOP CORP | Consumer Cyclical | $9.82B | 0.46% |
44WULF | TERAWULF INC | Financial Services | $9.00B | 0.42% |
45OSCR | OSCAR HEALTH INC | Healthcare | $8.77B | 0.41% |
46PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | $8.77B | 0.41% |
47KTOS | KRATOS DEFENSE & SECURITY SOLUTIONS INC | Industrials | $8.63B | 0.40% |
48POWL | POWELL INDUSTRIES INC | Industrials | $8.48B | 0.39% |
49IMVT | IMMUNOVANT INC | Healthcare | $8.27B | 0.38% |
50MP | MP MATERIALS CORP | Basic Materials | $8.05B | 0.37% |
51ETSY | ETSY INC | Consumer Cyclical | $7.98B | 0.37% |
52RSI | RUSH STREET INTERACTIVE INC | Consumer Cyclical | $7.56B | 0.35% |
53MIRM | MIRUM PHARMACEUTICALS INC | Healthcare | $7.25B | 0.34% |
54CIFR | CIPHER DIGITAL INC | Financial Services | $7.18B | 0.33% |
55OKLO | OKLO INC | Utilities | $7.15B | 0.33% |
56DBX | DROPBOX INC | Technology | $7.14B | 0.33% |
57JOBY | JOBY AVIATION INC | Industrials | $7.11B | 0.33% |
58LQDA | LIQUIDIA CORP | Healthcare | $7.11B | 0.33% |
59FLR | FLUOR CORP | Industrials | $6.86B | 0.32% |
60CORZ | CORE SCIENTIFIC INC | Technology | $6.66B | 0.31% |
61NAVN | NAVAN INC | Technology | $6.60B | 0.31% |
62XENE | XENON PHARMACEUTICALS INC | Healthcare | $6.60B | 0.31% |
63FIGR | FIGURE TECHNOLOGY SOLUTIONS INC | Financial Services | $6.39B | 0.30% |
64SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $6.33B | 0.29% |
65DUOL | DUOLINGO INC | Technology | $6.24B | 0.29% |
66CVLT | COMMVAULT SYSTEMS INC | Technology | $6.10B | 0.28% |
67BLLN | BILLIONTOONE INC | Healthcare | $5.99B | 0.28% |
68DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | $5.77B | 0.27% |
69VSEC | VSE CORP | Industrials | $5.60B | 0.26% |
70TXG | 10X GENOMICS INC | Healthcare | $5.55B | 0.26% |
71KVYO | KLAVIYO INC | Technology | $5.29B | 0.25% |
72RELY | REMITLY GLOBAL INC | Technology | $5.08B | 0.24% |
73ANDG | ANDERSEN GROUP INC | Consumer Cyclical | $5.02B | 0.23% |
74PTRN | PATTERN GROUP INC | Consumer Cyclical | $4.97B | 0.23% |
75DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | $4.83B | 0.22% |
76CAI | CARIS LIFE SCIENCES INC | Healthcare | $4.66B | 0.22% |
77MANE | VERADERMICS INC | Healthcare | $4.65B | 0.22% |
78LIF | LIFE360 INC | Technology | $4.36B | 0.20% |
79CELC | CELCUITY INC | Healthcare | $4.31B | 0.20% |
80ALHC | ALIGNMENT HEALTHCARE INC | Healthcare | $4.26B | 0.20% |
81COCO | VITA COCO COMPANY INC | Consumer Defensive | $4.18B | 0.19% |
82TNGX | TANGO THERAPEUTICS INC | Healthcare | $4.13B | 0.19% |
83BETA | BETA TECHNOLOGIES INC | Industrials | $4.10B | 0.19% |
84MIAX | MIAMI INTERNATIONAL HOLDINGS INC | Financial Services | $4.02B | 0.19% |
85DYN | DYNE THERAPEUTICS INC | Healthcare | $3.92B | 0.18% |
86LASR | NLIGHT INC | Technology | $3.91B | 0.18% |
87CPRX | CATALYST PHARMACEUTICALS INC | Healthcare | $3.85B | 0.18% |
88PAY | PAYMENTUS HOLDINGS INC | Technology | $3.75B | 0.17% |
89PBLS | PARABILIS MEDICINES INC | Healthcare | $3.51B | 0.16% |
90USAR | USA RARE EARTH INC | Basic Materials | $3.49B | 0.16% |
91WRBY | WARBY PARKER INC | Healthcare | $3.24B | 0.15% |
92ONDS | ONDAS INC | Technology | $3.23B | 0.15% |
93CRVL | CORVEL CORP | Financial Services | $3.13B | 0.15% |
94EEFT | EURONET WORLDWIDE INC | Technology | $3.10B | 0.14% |
95LEU | CENTRUS ENERGY CORP | Basic Materials | $3.07B | 0.14% |
96WT | WISDOMTREE INC | Financial Services | $3.07B | 0.14% |
97USLM | UNITED STATES LIME & MINERALS INC | Basic Materials | $3.01B | 0.14% |
98FRSH | FRESHWORKS INC | Technology | $3.01B | 0.14% |
99XNDU | XANADU QUANTUM TECHNOLOGIES LTD | Technology | $2.98B | 0.14% |
100FIZZ | NATIONAL BEVERAGE CORP | Consumer Defensive | $2.91B | 0.14% |
101TDC | TERADATA CORP | Technology | $2.87B | 0.13% |
102AVPT | AVEPOINT INC | Technology | $2.80B | 0.13% |
103TNET | TRINET GROUP INC | Industrials | $2.74B | 0.13% |
104VISN | VISTANCE NETWORKS INC | Technology | $2.74B | 0.13% |
105SOUN | SOUNDHOUND AI INC | Technology | $2.71B | 0.13% |
106NVTS | NAVITAS SEMICONDUCTOR CORP | Technology | $2.68B | 0.12% |
107KOD | KODIAK SCIENCES INC | Healthcare | $2.67B | 0.12% |
108TMDX | TRANSMEDICS GROUP INC | Healthcare | $2.56B | 0.12% |
109PTON | PELOTON INTERACTIVE INC | Consumer Cyclical | $2.55B | 0.12% |
110IMNM | IMMUNOME INC | Healthcare | $2.53B | 0.12% |
111RUM | RUMBLE INC | Technology | $2.51B | 0.12% |
112BLBD | BLUE BIRD CORP | Consumer Cyclical | $2.48B | 0.12% |
113SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | $2.45B | 0.11% |
114BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | $2.36B | 0.11% |
115SLDE | SLIDE INSURANCE HOLDINGS INC | Financial Services | $2.35B | 0.11% |
116BHVN | BIOHAVEN LTD | Healthcare | $2.32B | 0.11% |
117NG | NOVAGOLD RESOURCES INC | Basic Materials | $2.27B | 0.11% |
118HCI | HCI GROUP INC | Financial Services | $2.27B | 0.11% |
119PVLA | PALVELLA THERAPEUTICS INC | Healthcare | $2.26B | 0.10% |
120PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.11B | 0.10% |
121SIND | SYNTHETIC INDUSTRIES INC | Consumer Cyclical | $2.03B | 0.09% |
122INOD | INNODATA INC | Technology | $1.99B | 0.09% |
123PLSE | PULSE BIOSCIENCES INC | Healthcare | $1.98B | 0.09% |
124AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | $1.97B | 0.09% |
125OCUL | OCULAR THERAPEUTIX INC | Healthcare | $1.96B | 0.09% |
126URGN | UROGEN PHARMA LTD | Healthcare | $1.96B | 0.09% |
127HRMY | HARMONY BIOSCIENCES HOLDINGS INC | Healthcare | $1.96B | 0.09% |
128DMRA | DAMORA THERAPEUTICS INC | Healthcare | $1.94B | 0.09% |
129ZBIO | ZENAS BIOPHARMA INC | Healthcare | $1.86B | 0.09% |
130MQ | MARQETA INC | Technology | $1.85B | 0.09% |
131BCAX | BICARA THERAPEUTICS INC | Healthcare | $1.82B | 0.08% |
132LIND | LINDBLAD EXPEDITIONS HOLDINGS INC | Industrials | $1.81B | 0.08% |
133STOK | STOKE THERAPEUTICS INC | Healthcare | $1.81B | 0.08% |
134ALMR | ALAMAR BIOSCIENCES INC | Healthcare | $1.80B | 0.08% |
135RVLV | REVOLVE GROUP INC | Consumer Cyclical | $1.78B | 0.08% |
136IMCR | IMMUNOCORE HOLDINGS PLC | Healthcare | $1.78B | 0.08% |
137ZYME | ZYMEWORKS INC | Healthcare | $1.77B | 0.08% |
138HYMC | HYCROFT MINING HOLDING CORP | Basic Materials | $1.74B | 0.08% |
139BFLY | BUTTERFLY NETWORK INC | Healthcare | $1.73B | 0.08% |
140TSHA | TAYSHA GENE THERAPIES INC | Healthcare | $1.71B | 0.08% |
141TRIP | TRIPADVISOR INC | Industrials | $1.70B | 0.08% |
142ANAB | ANAPTYSBIO INC | Healthcare | $1.69B | 0.08% |
143LIME | NEUTRON HOLDINGS INC | Technology | $1.68B | 0.08% |
144STDN | STANDARD NUCLEAR INC | Basic Materials | $1.67B | 0.08% |
145CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.67B | 0.08% |
146INVA | INNOVIVA INC | Healthcare | $1.60B | 0.07% |
147IDT | IDT CORP | Communication Services | $1.57B | 0.07% |
148MAZE | MAZE THERAPEUTICS INC | Healthcare | $1.56B | 0.07% |
149AMBQ | AMBIQ MICRO INC | Technology | $1.55B | 0.07% |
150VOYG | VOYAGER TECHNOLOGIES INC | Industrials | $1.53B | 0.07% |
151XZO | EXZEO GROUP INC | Financial Services | $1.46B | 0.07% |
152VIA | VIA TRANSPORTATION INC | Technology | $1.46B | 0.07% |
153TRS | TRIMAS CORP | Consumer Cyclical | $1.46B | 0.07% |
154MLTX | MOONLAKE IMMUNOTHERAPEUTICS | Healthcare | $1.45B | 0.07% |
155ARLO | ARLO TECHNOLOGIES INC | Basic Materials | $1.45B | 0.07% |
156WOLF | WOLFSPEED INC | Technology | $1.44B | 0.07% |
157AMPX | AMPRIUS TECHNOLOGIES INC | Industrials | $1.44B | 0.07% |
158TWFG | TWFG INC | Financial Services | $1.43B | 0.07% |
159WBTN | WEBTOON ENTERTAINMENT INC | Technology | $1.41B | 0.07% |
160OMDA | OMADA HEALTH INC | Healthcare | $1.41B | 0.07% |
161WINA | WINMARK CORP | Consumer Cyclical | $1.39B | 0.06% |
162REAL | THEREALREAL INC | Consumer Cyclical | $1.35B | 0.06% |
163AKTS | AKTIS ONCOLOGY INC | Healthcare | $1.33B | 0.06% |
164LZ | LEGALZOOMCOM INC | Industrials | $1.33B | 0.06% |
165PBT | PERMIAN BASIN ROYALTY TRUST | Energy | $1.32B | 0.06% |
166NSSC | NAPCO SECURITY TECHNOLOGIES INC | Industrials | $1.29B | 0.06% |
167IE | IVANHOE ELECTRIC INC | Basic Materials | $1.29B | 0.06% |
168INBX | INHIBRX BIOSCIENCES INC | Healthcare | $1.28B | 0.06% |
169TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Unclassified | $1.27B | 0.06% |
170AVLN | AVALYN PHARMA INC | Healthcare | $1.25B | 0.06% |
171FCEL | FUELCELL ENERGY INC | Industrials | $1.25B | 0.06% |
172IRMD | IRADIMED CORP | Healthcare | $1.24B | 0.06% |
173LQDT | LIQUIDITY SERVICES INC | Consumer Cyclical | $1.23B | 0.06% |
174SDGR | SCHRODINGER INC | Healthcare | $1.14B | 0.05% |
175WVE | WAVE LIFE SCIENCES LTD | Healthcare | $1.12B | 0.05% |
176PRCT | PROCEPT BIOROBOTICS CORP | Healthcare | $1.09B | 0.05% |
177SHAZ | SHARONAI HOLDINGS INC | Technology | $1.07B | 0.05% |
178GRPN | GROUPON INC | Communication Services | $1.06B | 0.05% |
179BIOA | BIOAGE LABS INC | Healthcare | $1.01B | 0.05% |
180FBRX | FORTE BIOSCIENCES INC | Healthcare | $1.00B | 0.05% |
181BBSI | BARRETT BUSINESS SERVICES INC | Industrials | $984M | 0.05% |
182VOR | VOR BIOPHARMA INC | Healthcare | $980M | 0.05% |
183ANRO | ALTO NEUROSCIENCE INC | Healthcare | $967M | 0.04% |
184LWLG | LIGHTWAVE LOGIC INC | Basic Materials | $960M | 0.04% |
185ANNX | ANNEXON INC | Healthcare | $950M | 0.04% |
186ROOT | ROOT INC | Financial Services | $944M | 0.04% |
187COUR | COURSERA INC | Consumer Defensive | $941M | 0.04% |
188RCAT | RED CAT HOLDINGS INC | Technology | $938M | 0.04% |
189APEI | AMERICAN PUBLIC EDUCATION INC | Consumer Defensive | $930M | 0.04% |
190EVER | EVERQUOTE INC | Communication Services | $925M | 0.04% |
191RDVT | RED VIOLET INC | Technology | $920M | 0.04% |
192LBRX | LB PHARMACEUTICALS INC | Healthcare | $901M | 0.04% |
193TBPH | THERAVANCE BIOPHARMA INC | Healthcare | $873M | 0.04% |
194PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | $873M | 0.04% |
195REPL | REPLIMUNE GROUP INC | Healthcare | $859M | 0.04% |
196SLDB | SOLID BIOSCIENCES INC | Healthcare | $859M | 0.04% |
197NNE | NANO NUCLEAR ENERGY INC | Industrials | $835M | 0.04% |
198CYRX | CRYOPORT INC | Industrials | $832M | 0.04% |
199AVR | ANTERIS TECHNOLOGIES GLOBAL CORP | Healthcare | $823M | 0.04% |
200UMAC | UNUSUAL MACHINES INC | Industrials | $809M | 0.04% |
201OFRM | ONCE UPON A FARM PBC | Consumer Defensive | $761M | 0.04% |
202METC | RAMACO RESOURCES INC | Basic Materials | $760M | 0.04% |
203ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $755M | 0.04% |
204DSP | VIANT TECHNOLOGY INC | Technology | $754M | 0.04% |
205CADL | CANDEL THERAPEUTICS INC | Healthcare | $746M | 0.03% |
206MNPR | MONOPAR THERAPEUTICS | Healthcare | $744M | 0.03% |
207IBTA | IBOTTA INC | Technology | $734M | 0.03% |
208AURA | AURA BIOSCIENCES INC | Healthcare | $723M | 0.03% |
209PKE | PARK AEROSPACE CORP | Industrials | $677M | 0.03% |
210SGP | SPYGLASS PHARMA INC | Healthcare | $661M | 0.03% |
211MNTN | MNTN INC | Technology | $661M | 0.03% |
212LPTH | LIGHTPATH TECHNOLOGIES INC | Technology | $657M | 0.03% |
213ACHV | ACHIEVE LIFE SCIENCES INC | Healthcare | $644M | 0.03% |
214FISN | DEEP FISSION INC | Industrials | $643M | 0.03% |
215TECX | TECTONIC THERAPEUTIC INC | Healthcare | $615M | 0.03% |
216FAC | FACTORIAL ENERGY INC | Industrials | $610M | 0.03% |
217NGNE | NEUROGENE INC | Healthcare | $590M | 0.03% |
218STTK | SHATTUCK LABS INC | Healthcare | $577M | 0.03% |
219IMMX | IMMIX BIOPHARMA INC | Healthcare | $558M | 0.03% |
220ELA | ENVELA CORP | Consumer Cyclical | $547M | 0.03% |
221ALOY | REALLOYS INC | Basic Materials | $544M | 0.03% |
222VSTM | VERASTEM INC | Healthcare | $530M | 0.02% |
223EROC | EAGLE ROCK ENERGY PARTNERS L P | Energy | $520M | 0.02% |
224ZURA | ZURA BIO LTD | Healthcare | $518M | 0.02% |
225NVCT | NUVECTIS PHARMA INC | Healthcare | $508M | 0.02% |
226XOMA | XOMA ROYALTY CORP | Healthcare | $504M | 0.02% |
227GDYN | GRID DYNAMICS HOLDINGS INC | Technology | $484M | 0.02% |
228SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $479M | 0.02% |
229PAYS | PAYSIGN INC | Technology | $478M | 0.02% |
230CWCO | CONSOLIDATED WATER CO LTD | Utilities | $467M | 0.02% |
231CLPT | CLEARPOINT NEURO INC | Healthcare | $454M | 0.02% |
232PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $453M | 0.02% |
233DCTH | DELCATH SYSTEMS INC | Healthcare | $442M | 0.02% |
234BNTC | BENITEC BIOPHARMA INC | Healthcare | $439M | 0.02% |
235ASPN | ASPEN AEROGELS INC | Basic Materials | $425M | 0.02% |
236TENX | TENAX THERAPEUTICS INC | Healthcare | $420M | 0.02% |
237SWMR | SWARMER INC | Technology | $410M | 0.02% |
238CBIO | CRESCENT BIOPHARMA INC | Healthcare | $407M | 0.02% |
239MOBI | MOBIA MEDICAL INC | Healthcare | $404M | 0.02% |
240NATH | NATHANS FAMOUS INC | Consumer Cyclical | $393M | 0.02% |
241BBBY | BED BATH & BEYOND INC | Consumer Cyclical | $372M | 0.02% |
242GNE | GENIE ENERGY LTD | Utilities | $369M | 0.02% |
243FENC | FENNEC PHARMACEUTICALS INC | Healthcare | $365M | 0.02% |
244OSPRU | OSPREY ACQUISITION CORP III | Unclassified | $362M | 0.02% |
245NATR | NATURES SUNSHINE PRODUCTS INC | Consumer Defensive | $359M | 0.02% |
246MTRX | MATRIX SERVICE CO | Industrials | $342M | 0.02% |
247MRAM | EVERSPIN TECHNOLOGIES INC | Technology | $341M | 0.02% |
248CV | CAPSOVISION INC | Healthcare | $335M | 0.02% |
249RTAC | RENATUS TACTICAL ACQUISITION CORP I | Industrials | $329M | 0.02% |
250MPTI | M-TRON INDUSTRIES INC | Technology | $328M | 0.02% |
251BKKT | BAKKT INC | Technology | $323M | 0.02% |
252MSB | MESABI TRUST | Basic Materials | $320M | 0.01% |
253CARL | CARLSMED INC | Healthcare | $317M | 0.01% |
254OSS | ONE STOP SYSTEMS INC | Technology | $313M | 0.01% |
255BKTI | BK TECHNOLOGIES CORP | Technology | $307M | 0.01% |
256FHTX | FOGHORN THERAPEUTICS INC | Healthcare | $305M | 0.01% |
257OFLX | OMEGA FLEX INC | Industrials | $302M | 0.01% |
258KPET | KPET ULTRA PACELINE CORP | Industrials | $289M | 0.01% |
259UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.01% |
260MASS | 908 DEVICES INC | Healthcare | $278M | 0.01% |
261TSSI | TSS INC | Technology | $274M | 0.01% |
262SGHT | SIGHT SCIENCES INC | Healthcare | $274M | 0.01% |
263TTRX | TURN THERAPEUTICS INC | Healthcare | $272M | 0.01% |
264CEPO | CANTOR EQUITY PARTNERS I INC | Industrials | $271M | 0.01% |
265ALMU | AELUMA INC | Technology | $267M | 0.01% |
266CNXU | CONEXEU SCIENCES INC | Healthcare | $263M | 0.01% |
267LTBR | LIGHTBRIDGE CORP | Industrials | $256M | 0.01% |
268QTTB | Q32 BIO INC | Healthcare | $255M | 0.01% |
269SRZN | SURROZEN INC | Healthcare | $255M | 0.01% |
270VNME | VENDOME ACQUISITION CORP I | Industrials | $254M | 0.01% |
271RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | $243M | 0.01% |
272SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Industrials | $241M | 0.01% |
273GLSI | GREENWICH LIFESCIENCES INC | Healthcare | $240M | 0.01% |
274USAU | US GOLD CORP | Basic Materials | $235M | 0.01% |
275UTMD | UTAH MEDICAL PRODUCTS INC | Healthcare | $222M | 0.01% |
276REA | RARE EARTHS AMERICAS INC | Basic Materials | $220M | 0.01% |
277ATOM | ATOMERA INC | Technology | $218M | 0.01% |
278KPTI | KARYOPHARM THERAPEUTICS INC | Healthcare | $216M | 0.01% |
279KROS | KEROS THERAPEUTICS INC | Healthcare | $211M | 0.01% |
280GSIT | GSI TECHNOLOGY INC | Technology | $208M | 0.01% |
281RNA | ATRIUM THERAPEUTICS INC | Healthcare | $208M | 0.01% |
282IMUX | IMMUNIC INC | Healthcare | $207M | 0.01% |
283DTIL | PRECISION BIOSCIENCES INC | Healthcare | $203M | 0.01% |
284AMWL | AMERICAN WELL CORP | Healthcare | $199M | 0.01% |
285TNXP | TONIX PHARMACEUTICALS HOLDING CORP | Healthcare | $198M | 0.01% |
286ACOG | ALPHA COGNITION INC | Healthcare | $185M | 0.01% |
287EGAN | EGAIN CORP | Technology | $180M | 0.01% |
288INGN | INOGEN INC | Healthcare | $178M | 0.01% |
289KVHI | KVH INDUSTRIES INC | Technology | $178M | 0.01% |
290KRRO | KORRO BIO INC | Healthcare | $177M | 0.01% |
291ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $172M | 0.01% |
292NUCL | EAGLE NUCLEAR ENERGY CORP | Basic Materials | $166M | 0.01% |
293OWLT | OWLET INC | Healthcare | $162M | 0.01% |
294TRAK | REPOSITRAK INC | Technology | $160M | 0.01% |
295UNCY | UNICYCIVE THERAPEUTICS INC | Healthcare | $144M | 0.01% |
296ACNT | ASCENT INDUSTRIES CO | Basic Materials | $138M | 0.01% |
297OTAI | STARLINK AI ACQUISITION CORP | Industrials | $137M | 0.01% |
298PMN | PROMIS NEUROSCIENCES INC | Healthcare | $136M | 0.01% |
299AXR | AMREP CORP | Real Estate | $136M | 0.01% |
300FIRY | FIRY INC | Technology | $130M | 0.01% |
301VTVT | VTV THERAPEUTICS INC | Healthcare | $130M | 0.01% |
302AARD | AARDVARK THERAPEUTICS INC | Healthcare | $128M | 0.01% |
303JYNT | JOINT CORP | Healthcare | $127M | 0.01% |
304CUE | CUE BIOPHARMA INC | Healthcare | $126M | 0.01% |
305BUDA | BUDA JUICE INC | Unclassified | $121M | 0.01% |
306SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $120M | 0.01% |
307AMCI | AMC ROBOTICS CORP | Technology | $114M | 0.01% |
308CODA | CODA OCTOPUS GROUP INC | Industrials | $113M | 0.01% |
309USGO | US GOLDMINING INC | Basic Materials | $109M | 0.01% |
310RACC | RESEARCH ALLIANCE CORP III | Industrials | $101M | 0.00% |
311ROC | RANK ONE COMPUTING CORP | Technology | $98M | 0.00% |
312VRCA | VERRICA PHARMACEUTICALS INC | Healthcare | $96M | 0.00% |
313RLYB | RALLYBIO CORP | Healthcare | $87M | 0.00% |
314SOTK | SONO TEK CORP | Technology | $86M | 0.00% |
315NRXS | NEURAXIS INC | Healthcare | $84M | 0.00% |
316WATT | ENERGOUS CORP | Technology | $83M | 0.00% |
317CSPI | CSP INC | Technology | $82M | 0.00% |
318HNNA | HENNESSY ADVISORS INC | Financial Services | $79M | 0.00% |
319ROLR | HIGH ROLLER TECHNOLOGIES INC | Consumer Cyclical | $76M | 0.00% |
320ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $76M | 0.00% |
321LONA | LEONABIO INC | Healthcare | $68M | 0.00% |
322IMA | IMAGENEBIO INC | Healthcare | $61M | 0.00% |
323EDSA | EDESA BIOTECH INC | Healthcare | $59M | 0.00% |
324TACT | TRANSACT TECHNOLOGIES INC | Technology | $54M | 0.00% |
325INKT | MINK THERAPEUTICS INC | Healthcare | $53M | 0.00% |
326XLO | XILIO THERAPEUTICS INC | Healthcare | $53M | 0.00% |
327MCRB | SERES THERAPEUTICS INC | Healthcare | $52M | 0.00% |
328EXOZ | EXOZYMES INC | Healthcare | $51M | 0.00% |
329ACFN | ACORN ENERGY INC | Technology | $51M | 0.00% |
Full long-leg book as of July 2026 · cap-weighted · total market cap $2.15T. Hypothetical model holdings — not a registered fund’s portfolio.
Sector Breakdown
Portfolio Style
Size × value map of the long-leg book
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 92% toward Large, 80% toward Growth. +8% unclassified (43 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → July 2026; the right-hand end is the same value as the box’s dot. 329 names now. Hypothetical holdings — descriptive, not P&L.
Constraint checks
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Required<= 25.0%Actual27.5%Margin-2.5%Days required to liquidate the largest position at 20% of one day's dollar volume.
Required<= 7.0 daysActualunboundedMargin—
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
No verdict sits within 1.0pp of its limit.
Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700
Measured on the 2026-07 formation date across 329 holdings (cap-weighted). A different formation date can produce different verdicts.
Derivatives risk (Rule 18f-4)
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months
The estimators disagree about the verdict, not just the value — the choice of method decides the answer here. Historical VaR gives ratio 2.27 (fail) but Gaussian VaR gives 1.81 (pass). The pass/fail conclusion is an artefact of estimator choice, not a property of the strategy.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Since publication
Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Consistency across eras
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Returns
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | -1.1% | -12.5% |
| 3 yearsp.a. | 12.8% | -0.3% |
| 5 yearsp.a. | -7.5% | -15.9% |
| 10 yearsp.a. | 6.5% | -2.7% |
| Since inceptionp.a. | 4.1% | -2.4% |
| Year | Long leg | Long-short |
|---|---|---|
| 20267 mo | 3.6% | -11.0% |
| 2025 | 18.6% | 15.5% |
| 2024 | 10.5% | -5.6% |
| 2023 | 29.5% | 24.4% |
| 2022 | -50.5% | -51.3% |
| 2021 | -33.6% | -50.4% |
| 2020 | 72.7% | 76.0% |
| 2019 | 37.8% | 9.7% |
| 2018 | -2.7% | 3.6% |
| 2017 | 33.2% | 26.7% |
| 2016 | -0.9% | -16.9% |
| 2015 | -6.3% | 3.0% |
| 2014 | 7.4% | -3.6% |
| 2013 | 40.7% | 11.8% |
| 2012 | 17.4% | 7.5% |
| 2011 | -1.6% | -3.8% |
| 2010 | 22.0% | 4.1% |
| 2009 | 44.4% | 18.9% |
| 2008 | -45.7% | -13.5% |
| 2007 | 22.1% | 16.1% |
| 2006 | 9.1% | -7.8% |
| 2005 | 14.8% | 8.2% |
| 2004 | 8.6% | 0.1% |
| 2003 | 54.3% | 27.5% |
| 2002 | -28.6% | -13.8% |
| 2001 | -37.0% | -33.2% |
| 2000 | -50.7% | -58.0% |
| 1999 | 94.2% | 89.8% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
Fund Facts
Methodology
The Foundry Cash Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Cash signal and holds the top decile with the highest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Documents (draft — hypothetical)
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.